Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Global Open-label Extension Study to Observe the Long-term Safety and Efficacy of SerpinPC in Subjects with Hemophilia Who Completed a Sponsored SerpinPC Clinical Trial

NCT06568302 is registered in ClinicalTrials.gov with ApcinteX Ltd as lead sponsor.

NCT NCT06568302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06568302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Global Open-label Extension Study to Observe the Long-term Safety and Efficacy of SerpinPC in Subjects with Hemophilia Who Completed a Sponsored SerpinPC Clinical Trial
Lead sponsor
ApcinteX Ltd
Phase
Phase 3
Overall status
Terminated
Start date
July 11, 2024
Completion date
January 29, 2025
Enrollment
15 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a, hemophilia a with inhibitor, hemophilia b, hemophilia b with inhibitor